Abstract
Background
Huntington's disease (HD) is marked by irreversible loss of neuronal function for which currently no availability for disease‐modifying treatment exists. Advances in the understanding of disease progression can aid biomarker development, which in turn can accelerate therapeutic discovery.
Methods
We characterised the progression of altered dynamics of whole‐brain network states in the zQ175DN mouse model of HD using a dynamic functional connectivity (FC) approach to resting‐state fMRI and identified quasi‐periodic patterns (QPPs) of brain activity constituting the most prominent resting‐state networks.
Results
The occurrence of the normative QPPs, as observed in healthy controls, was reduced in the HD model as the phenotype progressed. This uncovered progressive cessation of synchronous brain activity with phenotypic progression, which is not observed with the conventional static FC approaches. To better understand the potential underlying cause of the observed changes in these brain states, we further assessed how mutant huntingtin (mHTT) protein deposition affects astrocytes and pericytes – one of the most important effectors of neurovascular coupling, along phenotypic progression. Increased cell‐type dependent mHTT deposition was observed at the age of onset of motor anomalies, in the caudate putamen, somatosensory and motor cortex, regions that are prominently involved in HD pathology as seen in humans.
Conclusion
Our findings provide meaningful insights into the development and progression of altered functional brain dynamics in this HD model and open new avenues in assessing the dynamics of whole brain states, through QPPs, in clinical HD research.
Highlights
Hyperactivity in the LCN‐linked regions within short QPPs observed before motor impairment onset.
DMLN QPP presents a progressive decrease in DMLN activity and occurrence along HD‐like phenotype development.
Breakdown of the LCN DMLN state flux at motor onset leads to a subsequent absence of the LCN DMLN QPP at an advanced HD‐like stage.
Keywords: astrocytes, biomarkers, Huntington's disease, large‐scale brain networks, neurodegeneration, pericytes, quasi‐periodic patterns, resting‐state fMRI, VEGF
Hyperactivity in the LCN‐linked regions within short QPPs observed before motor impairment onset.
DMLN QPP presents a progressive decrease in DMLN activity and occurrence along HD‐like phenotype development.
Breakdown of the LCN DMLN state flux at motor onset leads to a subsequent absence of the LCN DMLN QPP at an advanced HD‐like stage.
1. INTRODUCTION
Huntington's disease (HD) is the most prevalent monogenic neurodegenerative disorder and genetic dementia, characterised by the progressive loss of cognitive and motor function. 1 Despite the known genetic background, 2 , 3 there is insufficient understanding of the progression of the functional phenotype of HD. MRI neuroimaging has been the cornerstone in unravelling the brain's structural and functional alterations across HD progression due to its noninvasive nature, thus enabling the discovery of novel biomarkers. Currently, detection of striatal brain loss using volumetric MRI is by far the most sensitive and earliest biomarker, manifesting even 20 years prior to HD clinical motor diagnosis. 2 , 4 , 5 , 6 However, even with this method, brain loss has already occurred, which is both irreversible and can progressively worsen over time. There is a critical need for novel early detection methods prior to irreversible brain atrophy.
A promising but underexplored MRI technique in HD is resting‐state functional MRI (rsfMRI). 7 rsfMRI is used to investigate changes in large‐scale network connectivity, revealing the brain's functional architecture, which is organised in resting‐state networks (RSNs). 8 , 9 , 10 Mapping functional connectivity (FC) in both the healthy brain and in neurodegenerative diseases (ND), 11 , 12 including HD, has shown dysfunction in several RSNs7 before and after clinical motor diagnosis in people with HD (PwHD). 13 , 14 , 15 However, these findings represent static FC, which assumes a constant correlation between a pair of brain regions and flattens the changes in time. This provides only snapshots of th brain, while the activity states of the brain are highly dynamic. Neglecting the dynamics of brain activity leads to an incomplete picture of the disease's pathological effect on the brain, which significantly limits fundamental understanding, identification of biomarkers, and the development of novel therapies.
To address this issue, novel methods are utilised to account for time‐varying properties and identify dynamic brain states that underlie the RSNs. 16 , 17 These methods elucidate time‐evolving activity across whole brain spatial patterns, which have led to the discovery of quasi‐periodic patterns (QPPs) that encompass cyclic brain activity. 18 The most prominent human QPP, the primary QPP, represents the anti‐correlated activity of the two most dominant RSNs, the default‐mode network (DMN) and the task‐positive network (TPN). 19 Alterations in these dynamic brain states, as revealed by QPPs, have also been shown in several neuropsychiatric disorders. 20 , 21 While the presence of these dynamic brain patterns has been detected in the healthy human brain, they have not been evaluated in any humans presenting with ND. Recently, our lab has demonstrated the potential of QPPs to assess disease‐driven alterations in rodent models of ND, specifically Alzheimer's’ disease. 22 , 23
Here, we assessed the evolution of dynamic brain‐wide network changes across disease‐like progression in the zQ175DN knock‐in (KI) heterozygous (HET) mouse model of HD. This model is highly favoured due to its similarity in both the genetic background and phenotypic abnormalities that recapitulate closely several aspects of the human HD. These characteristics are based on multiple cellular, functional, microstructural, behavioural, and cognitive anomalies observed along the disease‐like phenotypic development, where motor alterations follow a temporal progression, starting from 6 months of age. 24 , 25 , 26 , 27 , 28 , 29 , 30 We hypothesised that QPPs can be used to detect functional alterations in whole brain activity in this HD mouse model that will give novel insights into the disease‐like phenotype and uncover changes at ages before brain atrophy is observed.
We found a progressive cessation of synchronous network activity in the mouse default mode‐like network (DMLN), whose gradual reduction in activation led to the absence of the primary QPP rodent homolog. These results were further validated in histological staining for cells of the neurovascular unit within the brain. Moreover, the retrosplenial cortex ‐ a central hub of the DMLN, showed asynchrony in the peak timing relationship with other regions irrespective of the network state of the QPP. This indicates a potential cause of the breakdown of DMLN activity, concurrent with the putative onset of motor deficits in this mouse model. Finally, using QPP projection, we found that the normative QPPs that occur in healthy controls were consistently and progressively reduced along phenotypic progression in this HD model. The initial reduced states were present even before brain volume loss, suggesting that this method holds great potential for its application in clinical HD research. Altogether, our results provide a significant understanding of the progression of brain circuitry alterations in this HD mouse model, which encourages exploring if similar differences can be detected in PwHD, even before brain atrophy and clinical motor diagnosis occur.
2. MATERIALS AND METHODS
2.1. In vivo resting‐state fMRI study
2.1.1. Animals
A total of 40 mice, male, age‐matched, HET (n = 20) zQ175DN KI and WT (n = 20) littermates (C57BL/6J background, CHDI‐81003019, JAX stock #029928) were purchased from Jackson Laboratory (Bar Harbor, ME, USA). Males in particular were chosen for this study based on previous work that reported males to follow similar pattern of brain volume changes as in PwHD. 31 Animals were delivered to the animal facility and were allowed to acclimatise to the current environment for at least one week before the start of the study. To avoid aggressive behaviour, the mice were single‐housed in individually ventilated cages, provided with food and water ad libitum, and continuously monitored for temperature and humidity under a 12 h light/dark cycle.
The zQ175DN KI (DN: delta neo) contains a human HTT exon 1 replacement for the mouse Htt exon 1, including a ∼180–220 CAG repeats long tract. This model is a version of the zQ175 KI 32 model, where the congenic C57BL6J is used as the strain background. 33 Development of motor deficits are detected by 6 months of age, frequently referred as the onset of phenoconversion. 34 The HET form of zQ175DN is a highly favourable model, which exhibits slow neuropathological progression, including an increase of mutant huntingtin (mHTT) protein aggregation from 3 until 12 months, starting in the striatum at 3 and later on, in the cortex, at 8 months of age. 35 A longitudinal rsfMRI study was performed in both the zQ175DN HET and WTs 36 at ages of 3, 6 and 10 months, following phenotypic progression. These data sets were also used in our previously published work. 27 , 30 The details on the rsfMRI and 3D image acquisition and image preprocessing steps are documented in Vasilkovska et al. 2023. 27
In brief, all MRI scans were acquired on a 9.4T Biospec Bruker scanner under a combination of isoflurane (0.5%; Isoflo®, Abbot Laboratories Ltd., USA) and medetomidine (0.075 mg/kg; Domitor, Pfizer, Karlsruhe, Germany) anaesthesia. rsfMRI scans were acquired with a T2*‐weighted single‐shot Echo‐Planar Imaging (EPI) sequence (12 slices, voxel dimensions (300 × 300 × 400) µm3, TR 500 ms, TE 15 ms, 1200 repetitions). The 3D anatomical scans were obtained using the 3D Rapid Acquisition with Refocused Echoes (RARE) sequence with voxel dimensions (78 × 78 × 78) µm3, TR 1800 ms, TE 42 ms. Image preprocessing steps consisted of realignment, three‐step spatial normalisation to an in‐house C57BL/6 atlas, in‐plane smoothing (twice voxel size), temporal filtering (0.01–0.2 Hz), quadratic detrending (QDT), voxel‐wise global signal regression (GSR), and normalisation to unit variance.
2.1.2. QPP analysis
QPP extraction was done at the group level for each age separately, since previously, we have shown an age‐dependent FC change in this HD model. 27 First, the preprocessed rsfMRI scans from all subjects were concatenated in one image series for WT and zQ175DN HET. A spatiotemporal pattern finding algorithm 37 was then applied, which extracts whole‐brain recurring patterns of BOLD activity in a user‐defined temporal window. Next, the optimal time window of the sliding template was estimated, 38 which resulted in two window sizes of 6TR (3 s) and 20TR (10 s). Consecutive BOLD image frames with the predefined window length from a random starting frame in the image series are taken as an initial template. Its similarity with the entire image series is then stepwise calculated by estimating its Pearson correlation with image‐series segments of the same window size and progressively shifting it by 1 TR. Image frames with local maxima of the resulting sliding template correlation (STC) that surpass a correlation threshold of 0.2 were then voxel‐wise averaged to form an updated template. The process was repeated using the updated template until the correlation coefficient between templates from consecutive iterations exceeded 0.99 at which point the template was referred to as a QPP. The entire procedure was reiterated for 200 random starting frames from the image series resulting in 200 short (6 TR) and 200 long (20 TR) QPPs.
For both short and long QPPs, in order to identify (dis)similar QPPs within the 200 QPPs, hierarchical clustering was performed on the Euclidean norm of both spatial and temporal domain distances. Robust clusters were determined based on several criteria: a minimum size of 5% of the total number of QPPs, a minimum of 5% occurrence from total occurrences, and the majority of QPPs within each cluster must occur at least in 80% and 50% of subjects for short and long QPPs, respectively. The representative QPP (rQPP) from each cluster was obtained as the QPP with the highest total correlation (summed across occurrences) with the image series.
To assess the recurring property of a QPP, occurrences of each rQPP for each subject were extracted based on the rQPP's STCs. The occurrence rate of a QPP is defined as the number of occurrences per minute (Occurrences/min).
At each age, short and long rQPPs from both WT and zQ175DN HET groups were projected onto the image series of the other group to identify their representative spatial pattern and occurrences in the other group. Projection involved the calculation of the STC of the rQPP from one group with the image series of the other group and finding its local maxima exceeding the threshold of 0T.2 that yielded the projected occurrence rates. Voxel‐wise averaging across projected occurrences resulted in the projected pattern in the other group.
2.1.3. QPP regression
To understand the contribution of QPPs to FC, linear regression of the rQPPs was performed within each group's image series. 22 The rQPP was convolved with its own STCs to create that QPP's image series. Further, this QPP image series was voxel‐wise regressed from the original image series, thus removing the QPP's influence on the BOLD signal. The residual scans were used to further assess the FC without the contribution of that QPP. The QPP regression was performed for short rQPPs in both WT and zQ175DN HET groups.
2.1.4. FC analysis
Static FC between selected regions of interest (ROIs) that pertain to four different networks: the DMLN, associative cortical network (ACN), lateral cortical network (LCN) and the Subcortical Network (SuCN) was calculated. We selected 26 unilateral ROIs (both left (L) and right (R) hemispheres for each region) from an in‐house C57BL6 mouse atlas 39 that represent the main hubs of several relevant large‐scale networks. 40 , 41 The abbreviations for each region are presented in Table 1. For each subject and each region, we extracted the time series of the region‐averaged BOLD signal. Pearson correlation coefficients were calculated between the BOLD signal time series of each pair of regions. These correlations were Fisher z‐transformed, thus obtaining subject‐wise FC matrices.
TABLE 1.
Network | Region | |
---|---|---|
DMLN | CgCtx | Cingulate cortex |
RspCtx | Retrosplenial cortex | |
PrlCtx | Prelimbic cortex | |
ACN | VCtx | Visual cortex |
AuCtx | Auditory cortex | |
LCN | S1Ctxb | Somatosensory cortex 1 (mouth) |
S2Ctx | Somatosensory cortex 2 | |
MCtx | Motor cortex | |
InsCtx | Insular cortex | |
FrACtx | Frontal association cortex | |
SuCN | mCPu | Caudate putamen, medial division |
lCPu | Caudate putamen, lateral division | |
PirCtx | Piriform cortex |
2.1.5. Regional peak timing relationship within a long rQPP
To understand the propagation of coordinated activity in key regions involved in the long QPPs and to unravel potential driving mechanisms, an adapted method for extraction of peak timing of regional (de)activation was applied. 19 The first step was the identification of significantly (de)activated voxels within the whole duration of 10 s of the long rQPP. To obtain these, we first constructed a null spatiotemporal pattern by voxel‐wise averaging across n, randomly selected, nonoverlapping segments that do not overlap with segments corresponding to occurrences of a QPP of interest, where n is the number of occurrences of that QPP within the image series. The number of random segments from a single subject corresponds to the number of times the QPP occurs in that subject. This process is repeated 50 times resulting in 50 null QPPs.
Next, the root sum square (RSS) of the voxel‐wise BOLD signal was calculated for each QPP of interest and the corresponding null QPPs. Thus, for each voxel, its BOLD signal for each of the 20‐time frames of the QPP was squared, summed across all frames and then a square root of this sum was taken. This resulted, for the 50 null QPPs, in 50 × 7688 RSS values, where N is the number of voxels in the brain mask we considered. Voxels whose RSS values in each long rQPP exceeded the 95 percentile of the null QPP RSS values were identified as significant and used for further analysis. These voxels were assigned to six regions: Caudate putamen (CPu), medial prefrontal cortex (mPFC), motor cortex (MCtx), Somatosensory cortex 1 (S1Ctx), retrosplenial cortex (RspCtx) and visual cortex (VCtx). Each voxel shows two peaks of absolute values of its BOLD signal during every occurrence segment of the QPP (e.g., in the long (10 s) rQPP, for most voxels in the S1Ctx, there is an activation (> 0) peak during the first 10 frames of the QPP segment (LCN) and a second peak of deactivation (< 0) during the last 10 frames of the QPP segment (DMLN)). For each voxel within the QPP, timings for both the first and second peaks are extracted for all occurrences of the long QPP. All timings for each active voxel were averaged across the occurrences within each group.
2.1.6. Statistical analysis
To visually inspect the significant voxel‐wise (de)activation that constitutes an rQPP, one‐sample T‐statistic maps were calculated based on the BOLD signal across all occurrences of that QPP in the image series (one‐sample T‐test, false‐discovery rate (FDR) corrected, p < 0.05, cluster size (k) ≥ 10). Between‐group differences in spatial voxel activations, occurrence rates and FC were cross‐sectionally compared for each age (Two‐sample T‐test, FDR corrected, p < 0.05, k ≥ 10). For a visual representation of the anatomy of prominent QPPs, the t‐statistics were transformed and upsampled to the high‐resolution Australian mouse brain MRI anatomical atlas 42 using transformation parameters calculated between the C57BL6 mouse atlas and the Australian mouse brain atlas. These visualisations were produced with MRIcroGL (McCausland Center for Brain Imaging, University of South Carolina, USA).
For the regional peak timings in the long rQPP, the mean timing for each peak across all activated voxels was first compared between genotypes (two‐sample T‐test, FDR corrected, p < 0.05). Separately for the first and second peak, the mean peak timing difference between every pair of regions, within a genotype (two‐sample T‐test, FDR, p < 0.05) was assessed. The final comparison identified region‐pairs whose peak timings relationship was significantly altered between genotypic groups (two‐sample T‐test, FDR corrected, p < 0.05). To compensate for the difference in the number of significantly activated voxels of different regions, we calculated the difference between the peak timing of each voxel of the smaller region with the mean (across voxels) peak timing of the bigger region for the last comparison. Multiple comparison corrections were applied for both metrics (timings of two peaks) and over all regions or region‐pairs (FDR, p < 0.05). All analysis steps and statistics were performed with MATLAB R2021a (Mathworks, Natick, MA).
2.2. Ex vivo immunofluorescence (IF) study
2.2.1. Brain preparation
To assess changes in astrocytes and pericytes in order to understand impairments in neurovascular coupling, an IF study was performed on 12 age‐matched, male WT (n = 6) and zQ175DN HET (n = 6) mice at each of the 3, 6, 8 and 12 months of age (48 animals in total). Cardiac perfusion was performed with PBS solution and 4% paraformaldehyde solution (PFA). Extracted brains were post‐fixed in 4% PFA at 4°C for 24 h, followed by 30% sucrose at 4°C for 72 h. Brains were cryo‐embedded in Tissue‐Tek® O.C.T. Compound (Sakura, Cat. # 4583) with a precision cryo‐embedding system and stored at –80°C. For sectioning, brains were embedded in an O.C.T.‐embedding medium. At Bregma lateral 2.52, 0.96 and 0.12 mm, sagittal sections of 30 µm were obtained using a Leica CM1950 cryomicrotome (Leica BioSystems, Belgium), thaw mounted on VWR Superfrost Plus micro slides (VWR, Leuven, Belgium) and dried for 2 h at 37°C.
2.2.2. IF staining
Sections were first acclimatised at room temperature (RT) and further rehydrated in PBS (Life Technologies, 7001–36) for 5 min. Next, antigen retrieval was done by incubation in citrate buffer pH 6.0 for 30 min at 80°C. After washing three times with PBS, permeabilisation and blocking of endogenous proteins were done with 0.5% Triton X‐100 and 10% normal donkey serum (NDS, Jackson Immunoresearch, 017‐000‐121) in PBS for 30 min, followed by donkey anti‐mouse IgG Fab fragment (1:40 in PBS, Jackson Immunoresearch, 715‐006‐151), blocking for 1 h at RT. Two stainings were performed where the following primary antibodies were applied in the first staining (1) 2B4 – marker for mHTT (1:200, Sigma Eldrich, Cat. # MAB5492) and CD13 – marker for pericytes (1:100, R&D Systems, Cat. # AF2335) diluted in PBS + 5% NDS and in the second staining (2) 2B4 (1:200, Sigma Eldrich, Cat. # MAB5492), GFAP – marker for reactive astrocytes (1:1000, Abcam, Cat. # ab4674) and VEGF (1:100, Thermo Fisher, Cat. # MA5‐32038) were diluted in 0.1% Triton X‐100 and 1% NDS in PBS and incubated overnight at RT. After washing with PBS, the fluorescent‐conjugated secondary antibodies were applied: (1) donkey anti‐mouse Cy5 (1:50, Jackson Immunoresearch, Cat. # 715‐175‐151) for 2B4 and donkey anti‐goat AF555 (1:200, Thermo Fisher, Cat. # A21432) for CD13 and (2) donkey anti‐chicken Cy3 (1:500, Jackson Immunoresearch, Cat. # 703‐166‐155), donkey anti‐mouse Cy5 (1:50, Jackson Immunoresearch, Cat. # 715‐175‐151) and donkey anti‐rabbit AF488 (1:200, Jackson Immunoresearch, 711‐545‐152) for VEGF with PBS for 1 h on RT. In the first staining, an additional subsequent 2 h incubation was done with Lectin‐Dylight 488 (1:25, Vector Laboratories, Cat. # DL‐1174). After washing, in both stainings, sections were covered with a coverslip with antifade mounting medium containing DAPI (VECTASHIELD® Antifade Mounting Medium with DAPI Cat. # H‐1500) and stored at 4°C.
2.2.3. IF image acquisition
Confocal images of the stained sections were acquired for 8 brain ROIs: medial (m) CPu (lateral 0.96 mm), lateral (l) CPu (lateral 2.52 mm), S1Ctx, MCtx 1, MCtx 2, Cingulate Cortex (CgCtx), Piriform Cortex (PiriCtx) and Insular Cortex (InsCtx) with a Perkin Elmer Ultraview Vox dual spinning disk confocal microscope, mounted on a Nikon Ti body using a 40× dry objective (numerical aperture 0.95). Lasers with wavelengths 405 nm, 488 nm, 561nm and 640 nm were used in combination with a quadruple dichroic and 445/60–525/50–615/70–705/90 emission filters. Detection was done on a Hamamatsu C9100‐50 camera. Image acquisition was done using the Volocity software. Per animal and brain region, 5 images were acquired in 30 axial positions separated by a 1 µm spacing and a pixel resolution of 0.1786 µm.
2.2.4. IF image processing and analysis
A macro script was written for FIJI image analysis 43 and is available on GitHub (https://github.com/DeVosLab/Huntington). This script is built on modules that were already integrated with similar image analysis pipelines previously developed. 44 , 45 , 46 In brief, 30 µm z‐stacks were divided into maximum projections of 5 µm substacks, with 2 µm in between each substack. In each projection, the DAPI channel was used to detect nuclei employing the Stardist‐trained convolutional network 47 after background correction and smoothing (Gaussian filter with a radius of 8 pixels) to suppress contrast variations. Identified nuclei were then filtered based on user‐defined area and circularity limits. To define a cell region, the nuclear region was concentrically dilated by 3.2 µm. Due to region‐dependent differences in signal distribution (e.g., 2B4 signal, Figure S10), we opted for region specific analysis settings that were applied for all animals and time points within the specified region. 2B4‐positive huntingtin spots were segmented based on a user‐defined threshold after background subtraction and multiscale Laplacian spot enhancement. Spots were further filtered based on user‐defined area and circularity filters. Nonspecific 2B4 staining in blood vessels was excluded from this analysis. Cells that contained at least one spot were identified as 2B4+ cells. 2B4 spot coverage was calculated as the sum of the area of all spots in a cell divided by the projected cell area. To identify blood vessels and CD13+ vascular regions in the maximum projections, a multiscale tubeness filter 48 , 49 and a user‐defined threshold were used on both the lectin and CD13 channels, respectively. CD13 coverage on blood vessels was defined as the area of the overlapping CD13+ regions and lectin+ regions divided by the total blood vessel area (lectin+) in a FOV. To quantify the area of GFAP+ regions, a Gaussian filter (7‐pixel kernel radius) was applied to the maximum projections after which a low user‐defined threshold was applied to detect all GFAP+ regions in the image.
After processing, data analysis was performed in R. 50 Cells that had a nuclear overlap with CD13+/GFAP+ pixels greater than 50% were assigned as CD13+ or GFAP+ cells respectively. All single‐cell data from substack projections were pooled for every image to obtain the final cell counts. Other variables (e.g., spot coverage) were averaged over all substack projections for each image.
2.2.5. IF statistical analysis
Image‐based outlier detection was applied using the median ± 3 × median absolute deviation as outer limits within each brain region and animal ID. If fewer than 3 images were retained, the animal ID was discarded from further analysis for the specific region. In the next step, all variables were averaged for each animal ID and region after which a similar ID‐based outlier detection was applied. For longitudinal assessment of all markers, Two‐way ANOVA was used with main factors of genotype and age and genotype × age interaction. In the case of interaction, post hoc comparisons (FDR correction for 10 comparisons, p < 0.05) were performed for values within each genotype across ages compared to a control age of 3 months and between genotypes per age. When no interaction was present, the model was recalculated only for the main effects and a post hoc comparison (FDR, p < 0.05) was performed for each effect separately (for age, comparisons are made to 3 months as a control). In the case of 2B4 occupancy in CD13+ and GFAP+ cells in the zQ175DN HET, two‐way ANOVA included main factor age and region and their interaction, where post hoc comparisons (FDR correction for 28 comparisons, p < 0.05) were performed for each region pair per age. All statistical analyses and graph visualisations were performed using GraphPad Prism (version 9.4.1 for Windows, GraphPad Software, San Diego, California USA, www.graphpad.com). Outlier detection was performed in R.
3. RESULTS
3.1. Representative short (LCN and DMLN) and long (LCN DMLN) QPPs
Spatiotemporal hierarchical clustering of short (3 s) QPPs revealed two robust clusters in both WT and zQ175 HET mice at every age (Figure S1A and B). As previously reported, short QPPs represent distinct singular brain states in the rodent brain. 18 , 22 , 23 , 38 The QPPs of the first cluster showed co‐activation of regions that represent the LCN, such as MCtx 1, MCtx 2, S1Ctxb, S2Ctx, lCPu, frontal association cortex (FrACtx) and insular cortex (InsCtx) and a simultaneous co‐deactivation of regions that represent the DMLN like CgCtx, RspCtx, pre‐infralimbic cortex (PrL/ILCtx), mCPu, S1Ctxa, dentate gyrus (DG), entorhinal cortex (EntCtx), auditory cortex (AuCtx) and olfactory area (OA). The QPPs belonging to the second cluster exhibited inverse activity with the co‐activation of DMLN and co‐deactivation of LCN regions. These short QPPs are further named LCN and DMLN QPP, based on the co‐activated networks they display (Figure 1A). To understand a more complex brain state periodicity, long (10 s) QPPs were extracted. Clustering revealed long QPPs that constitute an interchange of activity between the two dominant networks, where LCN transitions into DMLN activation (Figure 1B). This QPP is the rodent homolog of the human primary QPP. 19 Hence, characteristic short and long QPPs are present in both WT and zQ175DN HET mice.
3.2. Age‐specific spatial and temporal alterations in short (3 s) LCN and DMLN QPPs
Voxel‐wise differences were assessed based on the spatial properties of rQPPs, where two types of between‐group comparisons were conducted for the LCN and DMLN QPPs: first, differences in the spatial (de)activation between rQPPs from each group and the second, differences in the spatial (de)activation between each rQPP of one group and its projection in the other group. The first comparison accounted for differences in most prominent QPPs that were deemed to be similar based on visual inspection and spatial correlation while the second accounted for changes in (de)activation of group representations of the same QPP (native rQPP of one group vs. its projected pattern in the other group).
At 3 months of age, a comparison between the LCN rQPPs (Figure 2A) revealed reduced activation of the ventral portion of the caudate CPu (vcCPu) and VCtx while a higher activation was present in the S1Ctx, lCPu, InsCtx and PiriCtx in the zQ175DN HET mice as compared to WT mice (Figure 2B – left). Higher deactivation in the zQ15DN HET was found in the MCtx 2, CgCtx and the RspCtx and a portion of the VCtx (Figure 2B – left). Comparing WT LCN rQPP with its projection in zQ175DN HET, similar differences were observed (Figure 2B – right). On the other hand, the zQ175DN HET LCN rQPP revealed mainly decreased activation and deactivation in vcCPu and CgCtx respectively, when compared with its projection in WT (Figure S2 – left). The group‐specific DMLN rQPP (Figure 2C) revealed reduced activation in the RspCtx, CgCtx and VCtx and reduced deactivation in the MCtx 1, vcCPu, olfactory bulb (OB) and an inferior portion of InsCtx in the zQ175DN HET as compared to WT (Figure 2D – left). Interestingly, an increased deactivation was present in S1Ctx, S2Ctx, lCPu and superior portions of InsCtx in the zQ175DN HET group, the same regions that showed increased activation during the LCN rQPP, indicating a potential hyper‐activity compensatory mechanism. Comparison of the WT DMLN rQPP between genotypes revealed fewer differences with only decreased activation in the inferior portion of InsCtx and higher and lower deactivation in S1Ctx and MCtx 2, respectively (Figure 2D – right). zQ175DN HET DMLN rQPP differences were only restricted to reduced activation in VCtx (Figure S2 – right).
At 6 months of age, differences in group‐based LCN rQPP (Figure S3A) revealed increased activation in the lCPu, S1Ctx, InsCtx and PiriCtx in the zQ175DN HET (Figure 3A – left), as at 3 months of age (Figure 2B), and reduced deactivation in RspCtx. Moreover, a robustly reduced activation was observed bilaterally in the S2Ctx and some portions of S1Ctx, also found when WT and zQ175DN HET‐specific LCN rQPPs were compared with their projections in the other group (Figures 3A – right and S3B). The group‐based DMLN rQPP (Figure S3C) comparison showed alterations in zQ175DN HET with an overall decreased activation in DMLN‐related regions (RspCtx, CgCtx, hippocampus (HC)), VCtx and OB, while an increased activation was observed in the thalamus (Thal), mCPu, nucleus accumbens (NAcc) and in the superior portion of the superior colliculus (SC; Figure 3B – left). Additionally, reduced deactivation was found in the lCPu, S1Ctx and lower portion of SC. DMLN‐region diminished activation was also present in the WT or zQ175DN HET‐based DMLN rQPP comparisons with their projections in the other group (Figures 3B – right and S3D); however, the remaining differences as observed in the group‐based rQPP, here, were less present.
At 10 months of age, along with the reduced activation observed bilaterally in the S2Ctx, as it was at 6 months, a reduction in activation in NAcc was also found (Figure 3C – left) in the zQ175 DN HET when LCN rQPPs from each group (Figure S4A) were directly compared. Higher activation was found in the lCPu and reduced deactivation in the VCtx and HC. Similar changes were found when zQ175DN HET‐based rLCN QPP was compared with its projection in WT (Figure S4B), but WT LCN rQPP showed no significant differences when compared with its projection in zQ175DN HET (Figure 3C – right). Interestingly, direct comparison of group‐based DMLN rQPPs showed significant differences across the pattern, with a robustly decreased DMLN‐region activation, increased activation in the Thal, increased deactivation in the S1Ctx and decreased deactivation in the OB and SC (Figure 3D – left). These whole‐brain differences indicate that this rQPP of the zQ175DN HET is a phenotypically distinct rQPP. While the WT DMLN rQPP showed no difference with its projection in zQ175 DN HET (Figure 3D – right), the zQ175DN HET DMLN rQPP showed several differences with reduced activation in CgCtx and VCtx and increased activation in one portion of the Thal (Figure S4D).
Next, we compared the temporal properties, namely the occurrences of rQPPs. Here, the comparison was made between the occurrences of rQPP from each group with that of its projection in the other. The occurrence rate of the WT LCN rQPP was significantly reduced in zQ175DN HET at 3 (p = 0.0194) and 10 (p = 0.0097; Figure 4A and C) but not at 6 months of age (p = 0.2116; Figure 4B). However, WT DMLN rQPP showed significantly reduced occurrences in zQ175DN HET at all ages (3 months: p = 0.0311; 6 months: p = 0.0012; 10 months: p = 2E‐06; Figure 4). Conversely, occurrence rates of both QPPs identified in the zQ175DN HET did not differ from those of their projections in WT at any age. This indicates that the normative WT LCN and DMLN rQPP are present and progressively diminish in occurrence in the zQ175DN HET group, while the zQ175DN HET rQPPs are present in the WT group and do occur as frequently as in the zQ175DN HET group. We conclude that genotypic differences in regional activation of LCN and DMLN rQPPs are age‐related, whereas the consistently decreased occurrence of the WT rQPP indicates that the predominant network states in the zQ175DN HET group are not normative.
3.3. LCN and DMLN rQPPs and their significance in FC alterations
As QPPs have been demonstrated as an important contributor to FC, 19 , 22 , 51 , 52 , 53 , 54 we investigated if the regression of the most prominent group‐specific LCN and DMLN QPPs from each group will influence FC genotypic differences. At 3 months, even though no significant FC differences were observed between groups (Figure S5A), regression of both short QPPs introduced a significantly higher FC between VCtx‐S2Ctx as compared to WT (Figure S5B). At 6 months, several pairs of regions that mostly pertain to DMLN and ACN showed a significantly reduced FC (Figure S5C), whereas after removing the respective rLCN and rDMLN QPP, these significant FC differences disappeared, implying that these QPPs contribute to the intergenotypic difference in FC (Figure S5D). From the two pairs of connections that showed differences in FC at 10 months (Figure S5E), after regression of both QPPs only the VCtx‐AuCtx connection disappeared. However, several ROI pairs pertaining mostly to DMLN and ACN were now found to be significantly different between genotypes (Figure S5F). Since the occurrence rates of both rQPPs were significantly lower in the zQ175DN HET group, regression of these QPPs had a larger impact on FCs in the WT group and resulted in higher net remnant FC in the zQ175DN HET group as compared to WT for several connections as observed in Figure S5F. This implies that the dominant group‐specific QPPs are relevant contributors to FC, as observed with the loss of genotypic differences linked to the presence of QPPs.
3.4. Progressive spatiotemporal alterations in long LCN DMLN (and DMLN LCN) QPPs
At 3 months, hierarchical clustering of long (10 s) QPPs revealed one cluster in both groups, whose rQPP demonstrated LCN activation–DMLN deactivation pattern transitioning into DMLN activation–LCN deactivation pattern (LCN DMLN rQPP; Figure 5A). Comparisons of voxel‐wise activations of each group's LCN DMLN rQPP were not performed due to the need for a phase shift of one group's rQPP to be aligned to the rQPP of the other group. Since this results in a shift (typically of 1TR), the phase‐aligned QPPs will not represent the true original QPP of that group. Therefore, we compared WT and zQ175DN HET rQPPs with their projections in the other group. WT LCN DMLN rQPP showed, in the first half (LCN activation fragment), increased activation of the lCPu, decreased activation of MCtx2 and decreased deactivation of DG, in the zQ175DN HET group (Figure 5B). However, for the zQ175DN HET LCN DMLN rQPP, the activation differences during LCN comprised of decreased activations in the MCtx2, iCPu, S1Ctx, S2Ctx and reduced deactivation in the DG as well as in the MCtx2 during DMLN activation (Figure S7A).
At 6 months, two clusters were present in both genotypes, with one of them showing the LCN DMLN QPP (Figure S6A) while the other showed an anticorrelated pattern (DMLN LCN QPP; Figure S6B). WT LCN DMLN rQPP showed differences only during the LCN fragment, namely, increased activation in the mCPu, InsCtx and decreased deactivation in the DG. Similar differences were observed in the case of zQ175DN HET LCN DMLN rQPP with additional bilateral reduced activation of S2Ctx and iCPu (Figure S7B). WT DMLN LCN rQPP was not different from its projection in the zQ175DN HET group, but zQ175DN HET rQPP showed, during the DMLN fragment, decreased activation of DMLN regions (RspCtx, CgCtx, HC) and the OB (Figure S7C). At 10 months, in the WT group, one LCN DMLN cluster was present; however, in the zQ175DN HET group, there was no robust cluster present but rather multiple heterogeneous clusters (Figure S1D), suggesting that in this group, the long QPP comprising of a transition between the two anticorrelated RSNs (LCN+/DMLN– to LCN–/DMLN+) within the window of 10 s is no longer present at this age.
A comparison of occurrences for the LCN DMLN rQPPs at 3 months showed no significant differences for either WT‐ or zQ175DN HET‐based rQPP (Figure 5C). At 6 months, WT LCN DMLN (p = 0.001) and DMLN LCN rQPPs (p = 0.001) showed a significant decrease in occurrence rates when compared with their projections, but no differences were found in the occurrence rates of zQ175DN HET rQPPs and their respective projections in WT (Figure 5E). Thus, long QPPs, the homolog of the human QPP1, show age‐related spatial activation differences and decreased normative occurrence of the WT rQPPs in the zQ175DN HET group. Moreover, the age‐related decrease of the DMLN leads to a breakdown of the LCN DMLN flux state in the zQ175DN HET group.
3.5. Regional timing differences during long LCN DMLN (and DMLN LCN) QPPs
To understand the possible driving mechanisms of coordinated activity in brain dynamics represented by the long QPPs, we investigated the relationship between timings of six prominent regions’ peak of activity during both LCN and DMLN fragments, similar to what has been shown in humans. 19 We hypothesised that due to the already observed alterations in the QPP properties, activity propagation would also be altered in the zQ175DN HET mice. Here, for 3 and 6 months, we compared regional peak timings and interregional peak timing relationships for each of the two peaks of activation in the WT long rQPPs with their projections in the zQ175DN HET. At 3 months, in the WT LCN DMLN rQPP, during the LCN fragment, the mean peak timing of mPFC (p = 0.0111), MCtx (p = 0.003) and RspCtx (p = 0.0113) showed a significant delay in zQ175DN HET as compared to WT (Figure S8A). When assessing the interregional relationship in peak timing, in both groups, the MCtx succeeded in all other regions except mPFC in the zQ175DN HET (Figure S8B). Moreover, in both groups, CPu and S1Ctx preceded the mPFC; however, only in the WT group, both regions also peaked before the VCtx. The delayed peak in mPFC, MCtx and RspCtx in the zQ175DN HET group led to significantly longer interregional peak intervals with the VCtx as compared to WT (Figure S8C). During DMLN activation, MCtx (p = 7.36E‐05) and S1Ctx (p = 0.0089) had a significantly delayed peak of de‐activation (Figure S8D) in zQ175 DN HET. In WT, mPFC and the VCtx preceded all other regions and CPu peaked significantly before MCtx, while the S1Ctx peaked last, but within the zQ175DN HET group, all other regions peaked before both MCtx and S1Ctx (Figure S8E). Intergenotypic comparisons revealed that the MCtx had altered interregional peak relationship with all other regions in the zQ175DN HET as compared to WT (Figure S8F).
At 6 months of age, timings were compared for WT LCN DMLN and DMLN LCN rQPPs. In the WT LCN DMLN rQPP, during the LCN activation, both S1Ctx (p = 3.04E‐05) and RspCtx (p = 0.0037) showed a significantly earlier mean peak timing (Figure 6A). Within WT, a significant difference in peak timing was observed for the CPu peak that precedes S1Ctx, while within zQ175DN HET, the VCtx is preceded by the S1Ctx and the RspCtx which also peaks before mPFC and the MCtx (Figure 6B). Genotypic differences showed that the premature peak timings in S1Ctx and RspCtx led to altered interpeak intervals with all other regions in the zQ175DN HET (Figure 6C).
During DMLN activation, both CPu (p = 3.72E‐04) and the MCtx (p = 3.0E‐04) showed a significantly delayed peak of deactivation while the RspCtx (p = 3.0E‐04) had a significantly earlier peak timing in the zQ175DN HET (Figure 6D). Within WT, CPu and mPFC preceded the peak timings of all other regions, while the VCtx and RspCtx peaked after all other regions with RspCtx peaking also after the VCtx (Figure 6E – top). However, within the zQ175DN HET group, the MCtx has a significantly lagged peak after all other regions except RspCtx (Figure 6E – bottom). Between‐group comparisons showed an altered relationship of the RspCtx with all other regions, but also of the VCtx with other regions except S1Ctx which in turn showed a significantly different peak timing relationship with CPu and MCtx in the zQ175DN HET as compared to WT (Figure 6F).
In the case of WT DMLN LCN rQPP, where the DMLN was first activated, in the zQ175DN HET, a significantly delayed S1Ctx peak of deactivation (p = 2.03E‐04) with an earlier peak of RspCtx (p = 0.0394) activation was observed (Figure S9A). In both groups, the VCtx peaked last. Additionally, in the zQ175DN HET, the S1Ctx succeeded all other regions (Figure S9B). Moreover, the CPu had an earlier peak compared to mPFC in the WT group. The lagged peak of the S1Ctx revealed altered interregional peak timing differences with mPFC, the VCtx and the RspCtx in zQ175DN HET with respect to the WT (Figure S9C). During LCN activation, a significantly delayed peak of CPu (p = 0.0394) and an earlier RspCtx peak (p = 0.0394) were present in the zQ175DN HET group (Figure S9D). In both groups, the mean peak timing of CPu preceded all other regions except mPFC in the zQ175DN HET (Figure S9E). Moreover, mPFC and S1Ctx peaked before the MCtx and the RspCtx peak lagged all other regions in both groups. Genotypic differences were observed in the altered relationship of CPu with RspCtx in the zQ175DN HET group (Figure S9F) due to the inverse directionality of intergenotypic change in the peak timings of these two regions. These results reveal that the nuanced timing relationship of different regions is affected in the zQ175DN HET group relative to WT. Specifically, a premature peak of the RspCtx regardless of the network state, indicates asynchrony of this region with respect to the others involved in the long QPPs.
3.6. mHTT deposition in pericytes across different ages
To find out whether the progressive deposition of mHTT correlated with the observed defects in QPPs, we quantified the 2B4‐positive spot coverage per cell (Figure 7A, see table S1). The 2B4 spot coverage showed a significant genotype × age interaction (two‐way ANOVA, p < 0.05) for all considered brain regions. Post hoc comparisons (FDR, p < 0, see ta.05) showed an increase of 2B4 spot coverage from 6 months onwards in both mCPu and lCPu but also in the InsCtx, PiriCtx and MCtx 2, while a significant increase in 2B4 spot coverage from 8 months onwards was found in MCtx 1, S1Ctx and CgCtx in the zQ175DN HET group (see Table S1; Figure 7B). When refining the analysis to pericytes, by limiting the quantification of the 2B4 spot coverage to CD13‐positive cells, we found no significant difference at 3 months, but a significant increase at 6 months in mCPu, S1Ctx and MCtx 2 (Figure 7D, see table S4). At 8 and 12 months of age, only mCPu and lCPu showed a significantly increased 2B4 spot coverage of CD13‐positive cells as compared to the other regions (Figure 7D, see table S4). This suggests that the CPu shows consistently increase in mHTT load across ages in pericytes; however, cortical regions show only a transient increase in mHTT load. Of note, these changes were independent of pericyte abundance since no significant differences were observed in the total CD13 area for any region (Figure S11A, see table S2). Genotypic comparison of the number of CD13‐positive cells revealed an interaction in lCPu and S1Ctx where post hoc comparisons showed that only at 6 months of age there was a trend of decrease (p = 0.063) and a significant decrease (p = 0.035) in cell count in the zQ175DN HET, respectively (Figure 7C, see table S3). In the MCtx 2, an overall higher cell count across ages was observed in zQ175DN HET as compared to WT. Together, these results demonstrate that, despite the lack of difference in total pericyte area, cortical regions show changes in pericyte abundance.
3.7. mHTT deposition in astrocytes and VEGF changes across different ages
To assess the mHTT occupancy within astrocytes, changes in 2B4 spot coverage within GFAP+ cells in the zQ175DN HET mice between regions per age were evaluated (two‐way ANOVA, p < 0.05). Whereas no differences were present at 3 months, astrocyte 2B4 spot coverage at 6 months, revealed that the mCPu was the only region that showed a significant increase in the 2B4 area occupied within GFAP cells, as compared to CgCtx and MCtx 2 (Figure 8B, see table S5). At 8 and 12 months of age, both the mCPu and PiriCtx had a significantly increased 2B4 spot coverage in GFAP+ cells as compared to the other regions (Figure 8B, see table S5). Additionally, as a measure of reactivity in astrocytes, we calculated the GFAP area (Figure 8C, see table S6), where only the lCPu showed an interaction with a significant increase in zQ175DN HET at 12 months (p = 0.01), whereas an overall increase in the InsCtx was present across ages. GFAP+ cell count comparison revealed no significant interaction for any of the regions, except for the InsCtx, with an overall increase in GFAP cell count in the zQ175DN HET mice (Figure S12B, see table S7). Altogether, we observe that mHTT load in astrocytes is consistently higher in the CPu and later on in the PiriCtx, as compared to other regions, whereas changes linked to astrogliosis were steadily present only in the InsCtx. VEGF has a direct association with both pericytes and astrocytes, 55 , 56 , 57 and its increase has been defined as a neuroprotective response to glutamate excitotoxicity, a prevailing hypothesis in HD. 58 , 59 , 60 Therefore, we measured the mean VEGF intensity to assess changes in this factor. From the 8 regions we investigated, lCPu, CgCtx, S1Ctx, InsCtx and PiriCtx had a significant interaction between genotype and age (see Table S8). Post hoc comparisons (FDR, p < 0.05) in these regions showed a markedly significant increase at 6 months in the zQ175DN HET group as compared to WT (Figure 8D). In addition, CgCtx showed a significant VEGF increase also at 8 months and the lCPu at 12 months of age. Overall, the pronounced increase in VEGF in the zQ175DN HET mice at 6 months could suggest a compensatory effect that coincides with the reported onset of motor deficits in this model. 34
4. DISCUSSION
Our study is the first comprehensive study of the evolution of dynamic recurring whole‐brain states in an HD model, represented by QPPs, which are relevant contributors to FC. These findings characterise the fine scale of instantaneous changes in the BOLD‐based alterations in HD, which show the aberrant evolution of the dynamics of the most prominent resting‐state networks – the DMLN and the LCN. Initial region‐specific hyperactivity in these QPPs was observed as a putative early compensation to maintain normal brain network function before any brain atrophy or motor disturbances are present, as reported in this HD model. 34 , 61 In addition, we found progressive cessation of the DMLN activity that led to a loss of the presence of the rodent homolog of the human primary QPP. These alterations occur when motor deficits and brain atrophy are present, 34 , 61 suggesting that the loss of network integrity could contribute to the phenotype progression in this HD mouse model. Moreover, the reduced occurrence of the normative QPPs of healthy controls in the HD mouse model suggests that QPP projection holds translational potential as a method to inform on the different disease stages in PwHD. With this study, we have described the dynamic whole brain network changes along phenotypic progression in an HD animal model, which can open new avenues of investigation when applied in clinical HD research. Furthermore, our work demonstrates that measuring dynamic brain states is a significant improvement over the current static FC methods – not only for preclinical investigation but also potentially for clinical HD research.
4.1. Diminished DMLN activity – an instigator for a breakdown of the LCN DMLN activation cycle
Previously, we found differences in FC starting in DMLN and ACN regions in the zQ175DN HET mice as compared to WT, at 6 months of age. 27 Here, we reveal dynamic QPP states already at 3 months with increased deactivation, and decreased activation in parts of the RspCtx, CgCtx, MCtx 2 and VCtx, all regions that are part of the core activation of DMLN. 62 Moreover, these regions showed a lagged peak of deactivation during LCN in the LCN DMN QPP, while the MCtx also lagged in its peak of activation in the DMLN segment, leading to altered relationships with the other regions. Deficits in neuronal synchrony in the motor cortex during nonmotion, measured with Ca2+ imaging, as well as electrophysiological alterations, were also reported at this age in the zQ175 mice, explaining a potential compensatory mechanism of motor network synchrony during motion. 63 , 64 Recently, increased intrinsic hyper‐excitability in the cortical pyramidal neurons of the S1Ctx at 3 months in the zQ175 mice was reported, aligning with our findings of increased activation in the S1Ctx at the same age. 65 At 6 months of age, our findings show a prominent reduction in BOLD de‐ and activation of the RspCtx in LCN and DMLN QPP, respectively, accompanied by reduced activation also in CgCtx and VCtx. This marked decrease in activation in the DMLN QPP was also seen in the reduced occurrence of this pattern in the zQ175DN HET mice. Remarkably, the RspCtx also showed a premature peak of either activation or deactivation in both long QPPs, indicating that there is an asynchronous peak in the BOLD activity that leads to altered time‐locked relationships with other regions. A recent study in zQ175DN mice of the same age reported altered mesoscale cortical activity in the RspCtx during a behavioural task where they report that initial behavioural deficits occur at this age, suggesting a potential role of the RspCtx in phenoconversion in this model. 66 The overall diminished DMLN activity at 10 months also led to a breakdown of the LCN DMLN state flux reflected in the lack of presence of the LCN DMLN QPP in the zQ175DN HET group, alongside the decreased occurrence of DMLN. Importantly, aligning with our findings, in a recent cross‐sectional study assessing dynamic FC in PwHD, alterations were observed after clinical motor diagnosis, where it was shown that PwHD tend to dwell in a lower FC state in regions pertaining to the DMN which in turn had also altered dynamic interplay with the executive control network (ECN), the human homologs of the DMLN and LCN, respectively. 67 Human FC has been shown to rely on a particular hierarchy that is reflected in cortical gradients of the RSNs, which shows variation from unimodal regions on one end, such as S1Ctx and S2Ctx, which are hard‐wired and have stronger structural‐functional coupling, and transmodal regions on the other end, which underly multi‐input integration, such as the DMN constituents, a major hub for incorporating cortical information. 68 , 69 , 70 , 71 This gradient cortical hierarchy was also found in mice, with similarities observed in both functional and long‐range axonal properties. 70 , 72 , 73 The transmodal DMLN regions play a central part in multimodal input; hence, they are highly adaptive to different types of information, therefore, playing a crucial role in normal sensory processing and integration. 71 , 72 However, in pathological conditions, these regions are more vulnerable to processes of neurodegeneration; this was observed in Parkinson's disease patients, where DMN shows higher structural‐functional decoupling in DMN, which was also linked to a decrease in dopamine transmission. 74 Our observations from both FC and dynamic analysis point towards the DMLN as the most vulnerable network in the zQ175DN HET that leads to a progressive prevalence of segregated states that pertain to the hard‐wired unimodal regions. To be able to better link the structural coupling to these changes, future investigations of T1w:T2w MRI could help in mapping the myelin‐based gradients in the cortex. 72 , 75
4.2. Nonnormative QPPs govern brain‐wide activity – a case for the neurodevelopmental hypothesis
We observed that the normative WT‐based QPPs are ubiquitously underrepresented at all ages in the zQ175DN HET group. Surprisingly, the zQ175DN HET‐based QPPs were present in the WT with the same occurrence. This suggests that the most dominant forms of DMLN and LCN QPPs in the zQ175DN HET group are a weaker state of these RSNs, as they still occur with the same frequency within the WT, but less than the normative QPPs. This implies a possible neurodevelopmental role underlying the RSNs in this model. A growing body of evidence supports the hypothesis that HD has neurodevelopmental origin. 76 , 77 , 78 , 79 , 80 This hypothesis posits that the mutated huntingtin gene alters specific brain regions and their circuits from birth, but these maladaptations are compensated for in early life, while these abnormal cells are in a quiescent‐like state. 78 During adulthood, normal ageing and epigenetic factors influence the breakdown of this protective mechanism which leads to the known neurodegenerative process. Many HD models have demonstrated cortical maldevelopment to have a short‐term change in a specific postnatal window that shows transient circuitry alterations but also brain volume abnormalities, which were observed in zQ175 male mice. 31 , 81 , 82 As regional volume postnatal changes are present in this model, 31 assessing how this impacts RSNs in this critical period would aid in better understating of the developmental effects on whole brain circuitry in HD. 79 , 83
4.3. mHTT deposition in astrocytes and pericytes linked to QPP alterations
Both astrocytes and pericytes have a role in the functional hyperaemia as a response to neuronal activity which forms the phenomenon of neurovascular coupling. As the basis of the fMRI BOLD signal stems from this coupling, cell‐specific alterations can create a cause/effect alteration in neuronal activity and thus in the functional connectivity of the brain. The role of astrocytes and their dysfunction in HD pathology is gaining attention as their impairment has been postulated to play a critical role in imbalanced glutamate homeostasis, the underlying cause of excitotoxicity in HD. 84 , 85 For the first time, we have characterised GFAP+ astrocytes across different cortical regions in this model, where at 6 months, despite no change in the total area which is indicative of astrogliosis, we observed an overall increase in 2B4 spot coverage with the mCPu showing the highest percentage. This increase in 2B4 spot coverage was also observed at 8 months in mCPu, lCPu and PiriCtx. In GFAP+ astrocytes, an increase in mHTT inclusion diameter was observed at the same age in the frontal cortex and striatum in this model. 86 However, S100ß+ cells, a marker for nonreactive astrocytes, showed more inclusions even from 6 months of age and it has been reported that this marker is more sensitive for staining all astrocytes. 86 , 87 , 88 Increases in mHTT coverage within astrocytes in the CPu and several cortical regions with the absence of astrogliosis can indicate the presence of functional alterations that can potentially influence the BOLD‐related alterations observed with QPPs. Moreover, an increase in GFAP+ area and cell count in the InsCtx was present across ages, which means that astrogliosis is present in this region. It is tempting to speculate that this susceptibility is due to the InsCtx being one of the transmodal regions in the functional gradients which is more sensitive under pathological conditions, such as the phenotype driven by mHTT expression in the zQ175DN HET model. 72 Pericytes are an integral part of the neurogliovascular unit, especially at the capillary level, where they regulate the vessel diameter in response to the energy demands of the brain. 89 , 90 Pericytes have not been well investigated in an HD context except for two studies – one in R6/2 mice and another using cell cultures from PwHD – that show decreased pericyte coverage in the cortex. 91 , 92 In our study, we characterise for the first time pericyte alterations in an HD model in several cortical and striatal regions across different ages. In the zQ175DN HET group, at 6 months of age, we observed increased 2B4 spot coverage in CD13+ pericytes in mCPu, S1Ctx and MCtx 2. Moreover, only at this age, decreased pericyte count was present in the S1Ctx and a trend of decrease in the CPu at this age. It can be inferred that loss of pericytes in these regions can be a transitory change, coinciding with the phenotypic conversion in this model, that is being compensated for after initial abnormalities occur. 34 , 66 Interestingly, these regions show consistent hyper(de)activations in QPPs. The MCtx 2, however, has an overall increase in pericytes across ages, which could allude to a developed maladaptation in this region. The presence of increased but potentially dysfunctional pericytes can influence neurovascular coupling, which could lead to overly constricted blood vessels with reduced blood flow as a response to neuronal activity. These postulated changes can be linked to the weaker (de)activation observed in the MCtx in QPPs. VEGF is typically known as a marker for angiogenesis; however, there are numerous functions linked to this factor and has been implicated in the etiology and treatment of NDs. 59 , 60 , 93 , 94 In R6/2 mice and cell cultures from PwHD, increases in VEGF are observed and linked to an increase in inflammatory‐prone astrocytes that leads to decreased pericyte coverage. 91 Our findings reveal a marked increase of VEGF in lCPu, S1Ctx, InsCtx and PiriCtx at 6 months of age, regions that have shown hyperactivation in QPPs. VEGF has neuroprotective effects, one of which is reducing vulnerability against glutamate excitotoxicity by inducing expression of the GluR2 subunit of the AMPA receptors. 58 Moreover, it has been shown that increase in VEGF protects in a dose‐dependent manner against mHTT aggregation, attenuation and general neuronal and medium spiny neuronal loss in the striatum. 59 In this study, changes in hyperactivation in these same regions in QPPs are also present earlier, at 3 months, which could suggest that initial changes on the circuitry level could induce the observed VEGF increase at 6 months, as a compensatory neuroprotective mechanism that results from aberrant corticostriatal connectivity.
4.4. Limitations
In this study, we used only zQ175 HET male mice since they exhibit brain volume changes, resembling what is observed in PwHD. 31 Since the cortico‐striato‐thalamic network comprises subsegregated regional circuitry, 95 , 96 to have a more granulated assessment of how these regions are altered in their timings during QPPs, future studies should employ a detailed whole brain parcellation to unravel these changes. Of note, all animals were single‐housed due to the aggressive phenotype that they exhibited at an early age. Social isolation has been implicated to have effects on brain physiology and function 97 ; however, as both genotypes were kept under the same conditions, the intergenotypic differences are mainly due to the HD phenotype. In our IF study, we did not observe changes in 2B4 spot coverage in cells at 3 months, despite this being shown in this model, using different markers, such as the antibodies S829 or S830, which observe changes starting even from 1–2 months of age. 86 , 98 Likewise, the use of S100ß as a marker for astrocytes would be a more appropriate replacement compared to GFAP, which only represents inflammatory states of astrogliosis. Moreover, we did not include the RspCtx as a region of interest; these markers should be assessed in this region as well as it clearly showed marked QPP changes. To disentangle the cell‐specific alterations in brain‐wide network dynamics, future studies should apply chemo‐ or optogenetic modulation specific to astrocytes or pericytes in combination with rsfMRI to observe in vivo brain‐wide changes pertaining to these cell types. A complementary behavioural assessment alongside the longitudinal rsfMRI time points would allow for a reliable link to the phenotypic evolution in this model and the deficits that develop at different ages which can potentially be linked to the observed brain network changes.
5. CONCLUSION
These findings demonstrate the importance and promise of investigating the whole‐brain network dynamics using QPPs, constituents of the brain's most prominent RSNs, in preclinical research. This method reveals changes in region‐specific activations, occurrences, and the interpeak relationship of regions that are involved in the networks as part of the QPPs. Most importantly, QPPs uncovered progressive cessation of synchronous brain activity with phenotypic progression, which is not observed with the conventional static FC approaches. This work opens new avenues in assessing the dynamics of whole brain states, through QPPs, in clinical HD research.
AUTHOR CONTRIBUTIONS
Tamara Vasilkovska, Mohit H. Adhikari, Marlies Verschuuren and Annemie Van der Linden designed the study. Annemie Van der Linden, Marlies Verschuuren and Winnok H. De Vos secured the funding. Tamara Vasilkovska, Johan Van Audekerke and Mohit H. Adhikari developed the rsfMRI processing and data analysis approach. Tamara Vasilkovska performed the rsfMRI experiments and analysis. Marlies Verschuuren and Tamara Vasilkovska performed the IF analysis. Tamara Vasilkovska and Marlies Verschuuren wrote the manuscript. Dorian Pustina, Roger Cachope, Isabel Pintelon, Winnok H. De Vos contributed with scientific input for improved rigor of the study. All authors have read, revised and approved of the final manuscript.
CONFLICT OF INTEREST STATEMENT
The authors declare that they have no competing interests.
ETHICS STATEMENT
All experiments and handling were done in accordance with the EU legislation regulations (EU directive 2010/63/EU) and were approved by the Ethical Committee for Animal Testing UAntwerp (ECD # 2017‐09).
Supporting information
ACKNOWLEDGEMENTS
We express our immense gratitude to Annemie Van Eeteveldt and Zoë Embrechts for their help with the immunofluorescence study. This work was funded by CHDI Foundation, Inc., a nonprofit biomedical research organisation exclusively dedicated to collaboratively developing therapeutics that will substantially improve the lives of HD‐affected individuals. The computational resources and services used in this work were provided by the HPC core facility CalcUA of the University of Antwerp, the VSC (Flemish Supercomputer Center), funded by the Hercules Foundation, and the Flemish Government department EWI. The Flemish Impulse funding for heavy scientific equipment under grant agreement number OZ3544 (granted to AVdL). MV, WDV, and IP are supported by the Research Foundation Flanders FWO (I000123N, I003420N).
Vasilkovska T, Verschuuren M, Pustina D, et al. Evolution of aberrant brain‐wide spatiotemporal dynamics of resting‐state networks in a Huntington's disease mouse model. Clin Transl Med. 2024;14:e70055. 10.1002/ctm2.70055
Mohit H. Adhikari and Marleen Verhoye are co‐senior authors.
Contributor Information
Tamara Vasilkovska, Email: tamara.vasilkovska@ucsf.edu.
Mohit H. Adhikari, Email: mohit.adhikari@uantwerpen.be.
DATA AVAILABILITY STATEMENT
The datasets used and/or analysed during the current study are available on the Mendeley data repository (https://doi.org/10.17632/dvtbkxwwhb.1 and https://dx.doi.org/10.17632/5r3nytnw2y.1).
REFERENCES
- 1. Ghosh R, Tabrizi SJ. Clinical features of Huntington's disease. Adv Exp Med Biol. 2018;1049:1‐28. doi: 10.1007/978-3-319-71779-1_1 [DOI] [PubMed] [Google Scholar]
- 2. Bates GP, Dorsey R, Gusella JF, et al. Huntington disease. Nat Rev Dis Primers. 2015;1:15005. doi: 10.1038/nrdp.2015.5 [DOI] [PubMed] [Google Scholar]
- 3. The Huntington's Disease Collaborative Research Group . A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72(6):971‐983. doi: 10.1016/0092-8674(93)90585-e [DOI] [PubMed] [Google Scholar]
- 4. Ross CA, Aylward EH, Wild EJ, et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol. 2014;10(4):204‐216. doi: 10.1038/nrneurol.2014.24 [DOI] [PubMed] [Google Scholar]
- 5. Georgiou‐Karistianis N, Scahill R, Tabrizi SJ, Squitieri F, Aylward E. Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials. Neurosci Biobehav Rev. 2013;37(3):480‐490. doi: 10.1016/j.neubiorev.2013.01.022 [DOI] [PubMed] [Google Scholar]
- 6. Scahill RI, Andre R, Tabrizi SJ, Aylward EH. Structural imaging in premanifest and manifest Huntington disease. Handb Clin Neurol. 2017;144:247‐261. doi: 10.1016/B978-0-12-801893-4.00020-1 [DOI] [PubMed] [Google Scholar]
- 7. Pini L, Jacquemot C, Cagnin A, et al. Aberrant brain network connectivity in presymptomatic and manifest Huntington's disease: a systematic review. Hum Brain Mapp. 2020;41(1):256‐269. doi: 10.1002/hbm.24790 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Lowe MJ, Dzemidzic M, Lurito JT, Mathews VP, Phillips MD. Correlations in low‐frequency BOLD fluctuations reflect cortico‐cortical connections. Neuroimage. 2000;12(5):582‐587. doi: 10.1006/nimg.2000.0654 [DOI] [PubMed] [Google Scholar]
- 9. Greicius MD, Krasnow B, Reiss AL, Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci USA. 2003;100(1):253‐258. doi: 10.1073/pnas.0135058100 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Fransson P. Spontaneous low‐frequency BOLD signal fluctuations: an fMRI investigation of the resting‐state default mode of brain function hypothesis. Hum Brain Mapp. 2005;26(1):15‐29. doi: 10.1002/hbm.20113 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Zhang HY, Wang SJ, Liu B, et al. Resting brain connectivity: changes during the progress of Alzheimer disease. Radiology. 2010;256(2):598‐606. doi: 10.1148/radiol.10091701 [DOI] [PubMed] [Google Scholar]
- 12. Luo C, Song W, Chen Q, et al. Reduced functional connectivity in early‐stage drug‐naive Parkinson's disease: a resting‐state fMRI study. Neurobiol Aging. 2014;35(2):431‐441. doi: 10.1016/j.neurobiolaging.2013.08.018 [DOI] [PubMed] [Google Scholar]
- 13. Poudel GR, Egan GF, Churchyard A, Chua P, Stout JC, Georgiou‐Karistianis N. Abnormal synchrony of resting state networks in premanifest and symptomatic Huntington disease: the IMAGE‐HD study. J Psychiatry Neurosci. 2014;39(2):87‐96. doi: 10.1503/jpn.120226 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Dumas EM, van den Bogaard SJ, Hart EP, et al. Reduced functional brain connectivity prior to and after disease onset in Huntington's disease. Neuroimage Clin. 2013;2:377‐384. doi: 10.1016/j.nicl.2013.03.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Wolf RC, Sambataro F, Vasic N, et al. Visual system integrity and cognition in early Huntington's disease. Eur J Neurosci. 2014;40(2):2417‐2426. doi: 10.1111/ejn.12575 [DOI] [PubMed] [Google Scholar]
- 16. Calhoun VD, Miller R, Pearlson G, Adali T. The chronnectome: time‐varying connectivity networks as the next frontier in fMRI data discovery. Neuron. 2014;84(2):262‐274. doi: 10.1016/j.neuron.2014.10.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Allen EA, Damaraju E, Plis SM, Erhardt EB, Eichele T, Calhoun VD. Tracking whole‐brain connectivity dynamics in the resting state. Cereb Cortex. 2014;24(3):663‐676. doi: 10.1093/cercor/bhs352 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Majeed W, Magnuson M, Keilholz SD. Spatiotemporal dynamics of low frequency fluctuations in BOLD fMRI of the rat. J Magn Reson Imaging. 2009;30(2):384‐393. doi: 10.1002/jmri.21848 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Yousefi B, Keilholz S. Propagating patterns of intrinsic activity along macroscale gradients coordinate functional connections across the whole brain. Neuroimage. 2021;231:117827. doi: 10.1016/j.neuroimage.2021.117827 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Wang K, Majeed W, Thompson G, Ying K, Zhu Y, Keilholz S. Quasi‐periodic pattern of fMRI contributes to functional connectivity and explores differences between Major Depressive disorder and control. Proc Int Soc Magn Reson Med. 2016:1683. [Google Scholar]
- 21. Abbas A, Bassil Y, Keilholz S. Quasi‐periodic patterns of brain activity in individuals with attention‐deficit/hyperactivity disorder. Neuroimage Clin. 2019;21:101653. doi: 10.1016/j.nicl.2019.101653 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Belloy ME, Shah D, Abbas A, et al. Quasi‐periodic patterns of neural activity improve classification of Alzheimer's disease in mice. Sci Rep. 2018;8(1):10024. doi: 10.1038/s41598-018-28237-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. van den Berg M, Adhikari MH, Verschuuren M, et al. Altered basal forebrain function during whole‐brain network activity at pre‐ and early‐plaque stages of Alzheimer's disease in TgF344‐AD rats. Alzheimers Res Ther. 2022;14(1):148. doi: 10.1186/s13195-022-01089-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Rangel‐Barajas C, Rebec GV. Overview of Huntington's disease models: neuropathological, molecular, and behavioral differences. Curr Protoc Neurosci. 2018;83(1):e47. doi: 10.1002/cpns.47 [DOI] [PubMed] [Google Scholar]
- 25. Menalled L, El‐Khodor BF, Patry M, et al. Systematic behavioral evaluation of Huntington's disease transgenic and knock‐in mouse models. Neurobiol Dis. 2009;35(3):319‐336. doi: 10.1016/j.nbd.2009.05.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Heikkinen T, Lehtimaki K, Vartiainen N, et al. Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock‐in mouse model of Huntington's disease. PLoS One. 2012;7(12):e50717. doi: 10.1371/journal.pone.0050717 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Vasilkovska T, Adhikari M, Van Audekerke J, et al. Resting‐state fMRI reveals longitudinal alterations in brain network connectivity in the zQ175DN mouse model of Huntington's disease. Neurobiol Dis. 2023;181:106095. doi: 10.1016/j.nbd.2023.106095 [DOI] [PubMed] [Google Scholar]
- 28. Vasilkovska T, Salajeghe S, Vanreusel V, et al. Longitudinal alterations in brain perfusion and vascular reactivity in the zQ175DN mouse model of Huntington's disease. J Biomed Sci. 2024;31(1):37. doi: 10.1186/s12929-024-01028-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Vidas‐Guscic N, van Rijswijk J, Van Audekerke J, et al. Diffusion MRI marks progressive alterations in fiber integrity in the zQ175DN mouse model of Huntington's disease. Neurobiol Dis. 2024;193:106438. doi: 10.1016/j.nbd.2024.106438 [DOI] [PubMed] [Google Scholar]
- 30. Adhikari MH, Vasilkovska T, Cachope R, et al. Longitudinal investigation of changes in resting‐state co‐activation patterns and their predictive ability in the zQ175 DN mouse model of Huntington's disease. Scientific Reports. 2023;13(1):10194. doi: 10.1038/s41598-023-36812-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Zhang C, Wu Q, Liu H, et al. Abnormal brain development in Huntington' disease is recapitulated in the zQ175 knock‐in mouse model. Cereb Cortex Commun. 2020;1(1):tgaa044. doi: 10.1093/texcom/tgaa044 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Menalled LB, Kudwa AE, Miller S, et al. Comprehensive behavioral and molecular characterization of a new knock‐in mouse model of Huntington's disease: zQ175. PLoS One. 2012;7(12):e49838. doi: 10.1371/journal.pone.0049838 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Southwell AL, Smith‐Dijak A, Kay C, et al. An enhanced Q175 knock‐in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes. Hum Mol Genet. 2016;25(17):3654‐3675. doi: 10.1093/hmg/ddw212 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Heikkinen T, Bragge T, Bhattarai N, et al. Rapid and robust patterns of spontaneous locomotor deficits in mouse models of Huntington's disease. PLoS One. 2020;15(12):e0243052. doi: 10.1371/journal.pone.0243052 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Carty N, Berson N, Tillack K, et al. Characterization of HTT inclusion size, location, and timing in the zQ175 mouse model of Huntington's disease: an in vivo high‐content imaging study. PLoS One. 2015;10(4):e0123527. doi: 10.1371/journal.pone.0123527 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Fox JGBS, Davisson MT, Newcomer CE, Quimby FW, Smith AL. The Mouse in Biomedical Research. 2nd ed. Elsevier; 2007:637‐672. [Google Scholar]
- 37. Majeed W, Magnuson M, Hasenkamp W, et al. Spatiotemporal dynamics of low frequency BOLD fluctuations in rats and humans. Neuroimage. 2011;54(2):1140‐1150. doi: 10.1016/j.neuroimage.2010.08.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Belloy ME, Naeyaert M, Abbas A, et al. Dynamic resting state fMRI analysis in mice reveals a set of Quasi‐Periodic Patterns and illustrates their relationship with the global signal. Neuroimage. 2018;180(Pt B):463‐484. doi: 10.1016/j.neuroimage.2018.01.075 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Praet J, Manyakov NV, Muchene L, et al. Diffusion kurtosis imaging allows the early detection and longitudinal follow‐up of amyloid‐beta‐induced pathology. Alzheimers Res Ther. 2018;10(1):1. doi: 10.1186/s13195-017-0329-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Liska A, Galbusera A, Schwarz AJ, Gozzi A. Functional connectivity hubs of the mouse brain. Neuroimage. 2015;115:281‐291. doi: 10.1016/j.neuroimage.2015.04.033 [DOI] [PubMed] [Google Scholar]
- 41. Bukhari Q, Schroeter A, Cole DM, Rudin M. Resting state fMRI in mice reveals anesthesia specific signatures of brain functional networks and their interactions. Front Neural Circuits. 2017;11:5. doi: 10.3389/fncir.2017.00005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Janke AL, Ullmann JF. Robust methods to create ex vivo minimum deformation atlases for brain mapping. Methods. 2015;73:18‐26. doi: 10.1016/j.ymeth.2015.01.005 [DOI] [PubMed] [Google Scholar]
- 43. Schindelin J, Arganda‐Carreras I, Frise E, et al. Fiji: an open‐source platform for biological‐image analysis. Nat Methods. 2012;9(7):676‐682. doi: 10.1038/nmeth.2019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. De Vos WH, Van Neste L, Dieriks B, Joss GH, Van Oostveldt P. High content image cytometry in the context of subnuclear organization. Cytometry A. 2010;77(1):64‐75. doi: 10.1002/cyto.a.20807 [DOI] [PubMed] [Google Scholar]
- 45. Verschuuren M, Verstraelen P, Garcia‐Diaz Barriga G, et al. High‐throughput microscopy exposes a pharmacological window in which dual leucine zipper kinase inhibition preserves neuronal network connectivity. Acta Neuropathol Commun. 2019;7(1):93. doi: 10.1186/s40478-019-0741-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Verstraelen P, Garcia‐Diaz Barriga G, Verschuuren M, et al. Systematic quantification of synapses in primary neuronal culture. iScience. 2020;23(9):101542. doi: 10.1016/j.isci.2020.101542 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Schmidt U, Weigert M, Broaddus C, Myers G. Cell Detection with Star‐Convex Polygons. Springer International Publishing; 2018:265‐273. [Google Scholar]
- 48. Longair MP, Schindelin J. “Tubeness” plugin for ImageJ.
- 49. Sato Y, Nakajima S, Shiraga N, et al. Three‐dimensional multi‐scale line filter for segmentation and visualization of curvilinear structures in medical images. Med Image Anal. 1998;2(2):143‐168. doi: 10.1016/s1361-8415(98)80009-1 [DOI] [PubMed] [Google Scholar]
- 50.Core Tea. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2014. [Google Scholar]
- 51. Thompson GJ, Pan WJ, Billings JC, et al. Phase‐amplitude coupling and infraslow (<1 Hz) frequencies in the rat brain: relationship to resting state fMRI. Front Integr Neurosci. 2014;8:41. doi: 10.3389/fnint.2014.00041 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Keilholz SD, Magnuson ME, Pan WJ, Willis M, Thompson GJ. Dynamic properties of functional connectivity in the rodent. Brain Connect. 2013;3(1):31‐40. doi: 10.1089/brain.2012.0115 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Thompson GJ, Pan WJ, Keilholz SD. Different dynamic resting state fMRI patterns are linked to different frequencies of neural activity. J Neurophysiol. 2015;114(1):114‐124. doi: 10.1152/jn.00235.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Abbas A, Belloy M, Kashyap A, et al. Quasi‐periodic patterns contribute to functional connectivity in the brain. Neuroimage. 2019;191:193‐204. doi: 10.1016/j.neuroimage.2019.01.076 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Ribatti D, Nico B, Crivellato E. The role of pericytes in angiogenesis. Int J Dev Biol. 2011;55(3):261‐268. doi: 10.1387/ijdb.103167dr [DOI] [PubMed] [Google Scholar]
- 56. Salhia B, Angelov L, Roncari L, Wu X, Shannon P, Guha A. Expression of vascular endothelial growth factor by reactive astrocytes and associated neoangiogenesis. Brain Res. 2000;883(1):87‐97. doi: 10.1016/s0006-8993(00)02825-0 [DOI] [PubMed] [Google Scholar]
- 57. Bonkowski D, Katyshev V, Balabanov RD, Borisov A, Dore‐Duffy P. The CNS microvascular pericyte: pericyte‐astrocyte crosstalk in the regulation of tissue survival. Fluids Barriers CNS. 2011;8(1):8. doi: 10.1186/2045-8118-8-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Bogaert E, Van Damme P, Poesen K, et al. VEGF protects motor neurons against excitotoxicity by upregulation of GluR2. Neurobiol Aging. 2010;31(12):2185‐2191. doi: 10.1016/j.neurobiolaging.2008.12.007 [DOI] [PubMed] [Google Scholar]
- 59. Ellison SM, Trabalza A, Tisato V, et al. Dose‐dependent neuroprotection of VEGF(1)(6)(5) in Huntington's disease striatum. Mol Ther. 2013;21(10):1862‐1875. doi: 10.1038/mt.2013.132 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Storkebaum E, Carmeliet P. VEGF: a critical player in neurodegeneration. J Clin Invest. 2004;113(1):14‐18. doi: 10.1172/JCI20682 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Liu H, Zhang C, Xu J, et al. Huntingtin silencing delays onset and slows progression of Huntington's disease: a biomarker study. Brain. 2021;144(10):3101‐3113. doi: 10.1093/brain/awab190 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Whitesell JD, Liska A, Coletta L, et al. Regional, layer, and cell‐type‐specific connectivity of the mouse default mode network. Neuron. 2021;109(3):545‐559. doi: 10.1016/j.neuron.2020.11.011. e8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Donzis EJ, Estrada‐Sanchez AM, Indersmitten T, et al. Cortical network dynamics is altered in mouse models of Huntington's disease. Cereb Cortex. 2020;30(4):2372‐2388. doi: 10.1093/cercor/bhz245 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Indersmitten T, Tran CH, Cepeda C, Levine MS. Altered excitatory and inhibitory inputs to striatal medium‐sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease. J Neurophysiol. 2015;113(7):2953‐2966. doi: 10.1152/jn.01056.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Wang Y, Ramandi D, Sepers MD, Mackay JP, Raymond LA. Age‐ and region‐dependent cortical excitability in the zQ175 Huntington disease mouse model. Hum Mol Genet. 2024;33(5):387‐399. doi: 10.1093/hmg/ddad191 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Wang Y, Sepers MD, Xiao D, Raymond LA, Murphy TH. Water‐reaching platform for longitudinal assessment of cortical activity and fine motor coordination defects in a Huntington disease mouse model. eNeuro. 2023;10(1). doi: 10.1523/ENEURO.0452-22.2022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Aracil‐Bolanos I, Martinez‐Horta S, Gonzalez‐de‐Echavarri JM, et al. Structure and dynamics of large‐scale cognitive networks in Huntington's disease. Mov Disord. 2022;37(2):343‐353. doi: 10.1002/mds.28839 [DOI] [PubMed] [Google Scholar]
- 68. Margulies DS, Ghosh SS, Goulas A, et al. Situating the default‐mode network along a principal gradient of macroscale cortical organization. Proc Natl Acad Sci U S A. 2016;113(44):12574‐12579. doi: 10.1073/pnas.1608282113 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Vazquez‐Rodriguez B, Suarez LE, Markello RD, et al. Gradients of structure‐function tethering across neocortex. Proc Natl Acad Sci U S A. 2019;116(42):21219‐21227. doi: 10.1073/pnas.1903403116 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Huntenburg JM, Yeow LY, Mandino F, Grandjean J. Gradients of functional connectivity in the mouse cortex reflect neocortical evolution. Neuroimage. 2021;225:117528. doi: 10.1016/j.neuroimage.2020.117528 [DOI] [PubMed] [Google Scholar]
- 71. Shafiei G, Baillet S, Misic B. Human electromagnetic and haemodynamic networks systematically converge in unimodal cortex and diverge in transmodal cortex. PLoS Biol. 2022;20(8):e3001735. doi: 10.1371/journal.pbio.3001735 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Fulcher BD, Murray JD, Zerbi V, Wang XJ. Multimodal gradients across mouse cortex. Proc Natl Acad Sci U S A. 2019;116(10):4689‐4695. doi: 10.1073/pnas.1814144116 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Chuang KH, Li Z, Huang HH, Khorasani Gerdekoohi S, Athwal D. Hemodynamic transient and functional connectivity follow structural connectivity and cell type over the brain hierarchy. Proc Natl Acad Sci U S A. 2023;120(5):e2202435120. doi: 10.1073/pnas.2202435120 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Zarkali A, McColgan P, Leyland LA, Lees AJ, Rees G, Weil RS. Organisational and neuromodulatory underpinnings of structural‐functional connectivity decoupling in patients with Parkinson's disease. Commun Biol. 2021;4(1):86. doi: 10.1038/s42003-020-01622-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Glasser MF, Van Essen DC. Mapping human cortical areas in vivo based on myelin content as revealed by T1‐ and T2‐weighted MRI. J Neurosci. 2011;31(32):11597‐11616. doi: 10.1523/JNEUROSCI.2180-11.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Kubera KM, Schmitgen MM, Hirjak D, Wolf RC, Orth M. Cortical neurodevelopment in pre‐manifest Huntington's disease. Neuroimage Clin. 2019;23:101913. doi: 10.1016/j.nicl.2019.101913 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Barnat M, Capizzi M, Aparicio E, et al. Huntington's disease alters human neurodevelopment. Science. 2020;369(6505):787‐793. doi: 10.1126/science.aax3338 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78. van der Plas E, Schultz JL, Nopoulos PC. The Neurodevelopmental hypothesis of Huntington's disease. J Huntingtons Dis. 2020;9(3):217‐229. doi: 10.3233/JHD-200394 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79. van der Plas E, Langbehn DR, Conrad AL, et al. Abnormal brain development in child and adolescent carriers of mutant huntingtin. Neurology. 2019;93(10):e1021‐e1030. doi: 10.1212/WNL.0000000000008066 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80. Mehler MF, Gokhan S. Mechanisms underlying neural cell death in neurodegenerative diseases: alterations of a developmentally‐mediated cellular rheostat. Trends Neurosci. 2000;23(12):599‐605. doi: 10.1016/s0166-2236(00)01705-7 [DOI] [PubMed] [Google Scholar]
- 81. Cepeda C, Oikonomou KD, Cummings D, et al. Developmental origins of cortical hyperexcitability in Huntington's disease: review and new observations. J Neurosci Res. 2019;97(12):1624‐1635. doi: 10.1002/jnr.24503 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Braz BY, Wennagel D, Ratie L, et al. Treating early postnatal circuit defect delays Huntington's disease onset and pathology in mice. Science. 2022;377(6613):eabq5011. doi: 10.1126/science.abq5011 [DOI] [PubMed] [Google Scholar]
- 83. Tereshchenko AV, Schultz JL, Bruss JE, Magnotta VA, Epping EA, Nopoulos PC. Abnormal development of cerebellar‐striatal circuitry in Huntington disease. Neurology. 2020;94(18):e1908‐e1915. doi: 10.1212/WNL.0000000000009364 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84. Khakh BS, Beaumont V, Cachope R, Munoz‐Sanjuan I, Goldman SA, Grantyn R. Unravelling and exploiting astrocyte dysfunction in Huntington's disease. Trends Neurosci. 2017;40(7):422‐437. doi: 10.1016/j.tins.2017.05.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. Khakh BS, Goldman SA. Astrocytic contributions to Huntington's disease pathophysiology. Ann N Y Acad Sci. 2023;1522(1):42‐59. doi: 10.1111/nyas.14977 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86. Jansen AH, van Hal M, Op den Kelder IC, et al. Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell‐type‐specific. Glia. 2017;65(1):50‐61. doi: 10.1002/glia.23050 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87. Tong X, Ao Y, Faas GC, et al. Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice. Nat Neurosci. 2014;17(5):694‐703. doi: 10.1038/nn.3691 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88. Diaz‐Castro B, Gangwani MR, Yu X, Coppola G, Khakh BS. Astrocyte molecular signatures in Huntington's disease. Sci Transl Med. 2019;11(514). doi: 10.1126/scitranslmed.aaw8546 [DOI] [PubMed] [Google Scholar]
- 89. Hall CN, Reynell C, Gesslein B, et al. Capillary pericytes regulate cerebral blood flow in health and disease. Nature. 2014;508(7494):55‐60. doi: 10.1038/nature13165 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90. Brown LS, Foster CG, Courtney JM, King NE, Howells DW, Sutherland BA. Pericytes and neurovascular function in the healthy and diseased brain. Front Cell Neurosci. 2019;13:282. doi: 10.3389/fncel.2019.00282 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91. Hsiao HY, Chen YC, Huang CH, et al. Aberrant astrocytes impair vascular reactivity in Huntington disease. Ann Neurol. 2015;78(2):178‐192. doi: 10.1002/ana.24428 [DOI] [PubMed] [Google Scholar]
- 92. Drouin‐Ouellet J, Sawiak SJ, Cisbani G, et al. Cerebrovascular and blood‐brain barrier impairments in Huntington's disease: potential implications for its pathophysiology. Ann Neurol. 2015;78(2):160‐177. doi: 10.1002/ana.24406 [DOI] [PubMed] [Google Scholar]
- 93. Lange C, Storkebaum E, de Almodovar CR, Dewerchin M, Carmeliet P. Vascular endothelial growth factor: a neurovascular target in neurological diseases. Nat Rev Neurol. 2016;12(8):439‐454. doi: 10.1038/nrneurol.2016.88 [DOI] [PubMed] [Google Scholar]
- 94. Ruiz de Almodovar C, Lambrechts D, Mazzone M, Carmeliet P. Role and therapeutic potential of VEGF in the nervous system. Physiol Rev. 2009;89(2):607‐648. doi: 10.1152/physrev.00031.2008 [DOI] [PubMed] [Google Scholar]
- 95. Foster NN, Barry J, Korobkova L, et al. The mouse cortico‐basal ganglia‐thalamic network. Nature. 2021;598(7879):188‐194. doi: 10.1038/s41586-021-03993-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96. Hintiryan H, Foster NN, Bowman I, et al. The mouse cortico‐striatal projectome. Nat Neurosci. 2016;19(8):1100‐1114. doi: 10.1038/nn.4332 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97. Mumtaz F, Khan MI, Zubair M, Dehpour AR. Neurobiology and consequences of social isolation stress in animal model‐A comprehensive review. Biomed Pharmacother. 2018;105:1205‐1222. doi: 10.1016/j.biopha.2018.05.086 [DOI] [PubMed] [Google Scholar]
- 98. Smith EJ, Sathasivam K, Landles C, et al. Early detection of exon 1 huntingtin aggregation in zQ175 brains by molecular and histological approaches. Brain Commun. 2023;5(1):fcad010. doi: 10.1093/braincomms/fcad010 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets used and/or analysed during the current study are available on the Mendeley data repository (https://doi.org/10.17632/dvtbkxwwhb.1 and https://dx.doi.org/10.17632/5r3nytnw2y.1).